| Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis RB Jones, JW Cohen Tervaert, T Hauser, R Luqmani, MD Morgan, ... New England Journal of Medicine 363 (3), 211-220, 2010 | 1252 | 2010 |
| Supplementary Online Content PJ Devereaux, P Alonso-Coello, M Walsh JAMA 307 (17), 2295-2304, 2012 | 678* | 2012 |
| Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension M Walsh, PJ Devereaux, AX Garg, A Kurz, A Turan, RN Rodseth, ... Anesthesiology 119 (3), 507-515, 2013 | 672 | 2013 |
| Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial BF Culleton, M Walsh, SW Klarenbach, G Mortis, N Scott-Douglas, ... Jama 298 (11), 1291-1299, 2007 | 635 | 2007 |
| Long-term patient survival in ANCA-associated vasculitis O Flossmann, A Berden, K de Groot, C Hagen, L Harper, C Heijl, ... Annals of the rheumatic diseases 70 (3), 488-494, 2011 | 497 | 2011 |
| Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes F Botto, P Alonso-Coello, MTV Chan, JC Villar, D Xavier, S Srinathan, ... Anesthesiology 120 (3), 564-578, 2014 | 430 | 2014 |
| Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody–associated vasculitis: A randomized controlled trial TF Hiemstra, M Walsh, A Mahr, CO Savage, K De Groot, L Harper, ... Jama 304 (21), 2381-2388, 2010 | 423 | 2010 |
| Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up L Harper, MD Morgan, M Walsh, P Hoglund, K Westman, O Flossmann, ... Annals of the rheumatic diseases 71 (6), 955-960, 2012 | 326 | 2012 |
| Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis M Walsh, O Flossmann, A Berden, K Westman, P Höglund, C Stegeman, ... Arthritis & Rheumatism 64 (2), 542-548, 2012 | 242 | 2012 |
| Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis M Walsh, O Flossmann, A Berden, K Westman, P Höglund, C Stegeman, ... Arthritis & Rheumatism 64 (2), 542-548, 2012 | 242 | 2012 |
| A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life M Walsh, B Culleton, M Tonelli, B Manns Kidney international 67 (4), 1500-1508, 2005 | 215 | 2005 |
| The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis—a simulation study K Thorlund, G Imberger, M Walsh, R Chu, C Gluud, J Wetterslev, G Guyatt, ... PloS one 6 (10), e25491, 2011 | 206 | 2011 |
| The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index M Walsh, SK Srinathan, DF McAuley, M Mrkobrada, O Levine, C Ribic, ... Journal of clinical epidemiology 67 (6), 622-628, 2014 | 196 | 2014 |
| Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery PJ Devereaux, BM Biccard, A Sigamani, D Xavier, MTV Chan, ... Jama 317 (16), 1642-1651, 2017 | 193 | 2017 |
| Kidney disease after preeclampsia: a systematic review and meta-analysis SD McDonald, Z Han, MW Walsh, HC Gerstein, PJ Devereaux American Journal of Kidney Diseases 55 (6), 1026-1039, 2010 | 189 | 2010 |
| Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis M Walsh, M James, D Jayne, M Tonelli, BJ Manns, BR Hemmelgarn Clinical Journal of the American Society of Nephrology 2 (5), 968-975, 2007 | 186 | 2007 |
| Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody–associated vasculitis: A meta‐analysis M Walsh, PA Merkel, A Mahr, D Jayne Arthritis care & research 62 (8), 1166-1173, 2010 | 185 | 2010 |
| Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial M Walsh, PA Merkel, CA Peh, W Szpirt, L Guillevin, CD Pusey, J DeZoysa, ... Trials 14 (1), 73, 2013 | 182 | 2013 |
| Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear M Walsh, A Casian, O Flossmann, K Westman, P Höglund, C Pusey, ... Kidney international 84 (2), 397-402, 2013 | 157 | 2013 |
| Association between multidisciplinary care and survival for elderly patients with chronic kidney disease BR Hemmelgarn, BJ Manns, J Zhang, M Tonelli, S Klarenbach, M Walsh, ... Journal of the American Society of Nephrology 18 (3), 993-999, 2007 | 156 | 2007 |
David JayneProfessor of Clinical Autoimmunity, University of CambridgeVerified email at cam.ac.uk
